eccogene glp-1 Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies eccogene glp-1 Oral Small-Molecule GLP-1

is funded by NIH NIDDK R01DK122167

Fatigue on GLP-1: The Side Effect Fewer People Expect If you're taking a GLP-1 medication such as Mounjaro (tirzepatide), Ozempic (semaglutide), Wegovy or Zepbound, youve likely heard about nausea, appetite suppression, or weight changes

Writing in Food Research International , the international team of researchers not that extracts from mat and guayusa may activate TGR5, which they describe as a nuclear receptor of relevance for the prevention and management of diabetes and metabolic syndrome because of its involvement in the regulation of energy expenditure and insulin sensitivity

But here is the critical nuance

Evens out skin tone and reduces dark spots

Shima Hadidchi, MD, is dedicated to offering the latest, evidence-based treatments for weight management and metabolic health